| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/10/2001 | EP1140149A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 10/10/2001 | EP1140141A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
| 10/10/2001 | EP1140136A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 10/10/2001 | EP1140120A2 Human brainiac-5 |
| 10/10/2001 | EP1140106A1 Treatment of diseases involving cyst formation |
| 10/10/2001 | EP1140052A2 Sensitizing agents for the treatment of skin lesions |
| 10/10/2001 | EP1140024A2 Particles for oral delivery of peptides and proteins |
| 10/10/2001 | EP1140020A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 10/10/2001 | EP1140019A1 Aerosol formulations for buccal and pulmonary application |
| 10/10/2001 | EP1140015A1 Polynucleotide compositions for intramuscular and intradermal administration |
| 10/10/2001 | EP0914151B1 Complex comprising antigen and cell constituent, method of preparing said complex and its therapeutic uses |
| 10/10/2001 | EP0840620B1 Il-8 antagonists for treatment of asthma |
| 10/10/2001 | EP0804233B1 Methods for the cultivation of infectious laryngotracheitis virus and egg drop syndrome virus |
| 10/10/2001 | EP0672157B1 Recombinant viruses comprising artificial proteolytic cleavage site |
| 10/10/2001 | EP0667898B1 Uses of the tau/neurofilament protein kinase pk40 |
| 10/10/2001 | CN1317043A Polypeptides and polynucleotides from coagulase-negative staphylocoui |
| 10/10/2001 | CN1317015A Human anti-factor IX/IXa antibodies |
| 10/10/2001 | CN1317013A Peptide fragments of cholera toxic B or enterotoxin B as vaccine adjuvants |
| 10/10/2001 | CN1316518A Dual-plasmid gene vaccine resisting against hepatitis B virus, and its preparing process and application |
| 10/10/2001 | CN1316437A Humanized neutralizing generatically engineering Fab antibody of hepatitis A virus |
| 10/10/2001 | CN1316431A Compound of polypeptide as antigen of hepatitis B virus and heat shock protein and its application |
| 10/10/2001 | CN1316279A X-ray magnetic therapy machine for PDT therapy of cancer by combining radiatherapy with chemicotherapy and its medicine |
| 10/10/2001 | CN1072508C Preparation of heterogenic animal high immune serum against duck pest and viral hepatitis |
| 10/10/2001 | CN1072507C Method for extracting yolk antibody |
| 10/10/2001 | CN1072506C Improved diplococuus meninigitidis polysaccharide conjugate vaccine |
| 10/10/2001 | CN1072505C Novel antibody system for biological response modifiers |
| 10/09/2001 | US6300476 Anti-peptide antibody against human cytochrome P450 3A4 |
| 10/09/2001 | US6300470 Amino acid sequence for the treatment of inflammatory pathology; microbiocides |
| 10/09/2001 | US6300310 Amino acid sequence with segments of polypeptides |
| 10/09/2001 | US6300308 Methods and compositions for inducing autoimmunity in the treatment of cancers |
| 10/09/2001 | US6300129 Transgenic non-human animals for producing heterologous antibodies |
| 10/09/2001 | US6300119 Stretococcal ERS |
| 10/09/2001 | US6300118 Plasmids comprising a genetically altered feline immunodeficiency virus genome |
| 10/09/2001 | US6300104 Producing large quantities of secretory immunoglobulin a molecules by transfecting a single cell type with an immunoglobulin containing a polynucleotide encoding a secretory component; collecting, purifying supernatant |
| 10/09/2001 | US6300102 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins |
| 10/09/2001 | US6300101 An outer surface protein; diagnosis of lyme disease; vaccines |
| 10/09/2001 | US6300097 A polypeptide; therapy and diagnosis of bacterial infections; upper respiratory infections, toxic shock syndrome, septic arthritis and intestinal disorders |
| 10/09/2001 | US6300094 Polynucleotides encoding a novel ABC transporter |
| 10/09/2001 | US6300090 Delivering antigens to proliferating and non-proliferating dendritic cells using a nonreplicating influenza viral vector; the dentritic cells will process and express the antigen which will then activate cd8 cytotoxic t lymphocytes |
| 10/09/2001 | US6300089 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 10/09/2001 | US6299884 Administering antigen to animal inpresence of an immunostimulating amount of an adjuvant formulation consisting of metabolizabel oil and emulsifier for increasing immune response to antigen |
| 10/09/2001 | US6299883 Tarf |
| 10/09/2001 | US6299882 UL54.5 of Marek's disease virus (MDV) |
| 10/09/2001 | US6299881 Mixing uronium salt reagent with soluble first moiety selected from polysaccharides and carbohydrates, mixing second moiety with first moiety, wherein second moiety is selected from proteins, peptides, lipoproteins, haptens, carbohydrates |
| 10/09/2001 | US6299880 Cell surface protein compounds |
| 10/09/2001 | US6299879 Methods of immunization by administering fibrinogen binding protein or fragments thereof |
| 10/09/2001 | US6299877 Used in therapy |
| 10/09/2001 | US6299876 Cytotoxic drug therapy |
| 10/09/2001 | US6299874 Administering vaccine conjugate consisting essentially of a live virus and a neutralizing factor bound to live virus; neutralizing factor is selected from the group consisting of antibodies and antibody fragments |
| 10/09/2001 | US6299873 Surgical removal or reduction of body burden of malignant cells and retention of some of those cells for subsequent use in immunotherapy; boron neutron-capture therapy is employed at radiation dosage below threshold for normal tissue necrosis |
| 10/09/2001 | US6299869 Human interferon-epsilon: a type I interferon |
| 10/09/2001 | US6299067 Bar code scanner with intuitive head aiming and collimated scan volume |
| 10/09/2001 | CA1341303C Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (adcc) treatment of cancer and other diseases |
| 10/07/2001 | CA2340936A1 Inhibitors for the formation of soluble human cd23 |
| 10/04/2001 | WO2001073435A1 Methods for detecting inflammation and inflammatory conditions |
| 10/04/2001 | WO2001073133A1 Compositions and methods for identifying and targeting cancer cells |
| 10/04/2001 | WO2001073132A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 10/04/2001 | WO2001073131A1 High specificity marker detection |
| 10/04/2001 | WO2001073080A2 Recombinant iron uptake proteins |
| 10/04/2001 | WO2001073078A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
| 10/04/2001 | WO2001073040A1 Clostridium difficile polypeptides and uses thereof |
| 10/04/2001 | WO2001073037A2 R5 protein, a cell-surface protective antigen of group b streptococci |
| 10/04/2001 | WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | WO2001073030A2 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 10/04/2001 | WO2001073027A2 Compositions and methods for therapy and diagnosis of colon cancer |
| 10/04/2001 | WO2001073026A2 43238, a novel g protein-coupled receptor and uses therefor |
| 10/04/2001 | WO2001073020A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter |
| 10/04/2001 | WO2001072846A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 10/04/2001 | WO2001072845A1 Use of cd25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract |
| 10/04/2001 | WO2001072839A2 Human g-protein coupled receptors |
| 10/04/2001 | WO2001072835A1 Family of human sodium cation channels and use thereof |
| 10/04/2001 | WO2001072831A2 Immunoregulator |
| 10/04/2001 | WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 10/04/2001 | WO2001072822A2 Genes involved in intestinal inflammatory diseases and use thereof |
| 10/04/2001 | WO2001072782A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 10/04/2001 | WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer |
| 10/04/2001 | WO2001072773A2 Genes isolated from dendritic cells, gene products and methods employing the same |
| 10/04/2001 | WO2001072721A2 Synergistic methods and compositions for treating cancer |
| 10/04/2001 | WO2001072340A1 Aids virus vaccine with the use of sendai virus vector |
| 10/04/2001 | WO2001072337A1 Proteins for use as carriers in conjugate vaccines |
| 10/04/2001 | WO2001072336A1 Compounds for targeting |
| 10/04/2001 | WO2001072333A1 Methods of therapy for non-hodgkin's lymphoma using a combination_of an antibody to cd20 and interleuking-2 |
| 10/04/2001 | WO2001072331A1 Immunostimulating properties of a fragment of tgf-beta |
| 10/04/2001 | WO2001072330A2 Method for immunostimulation using binding agents for the fc rec eptor of immunoglobulin a and for cancer cells or infections antigen |
| 10/04/2001 | WO2001072329A1 Compositions and methods for enhancing immunogenicity of antigens |
| 10/04/2001 | WO2001072325A1 Methods of blocking tissue destruction by autoreactive t cells |
| 10/04/2001 | WO2001072323A2 Use of insulin for the treatment of cartilagenous disorders |
| 10/04/2001 | WO2001072295A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/04/2001 | WO2001072294A2 Method of treating hepatitis delta viral infection |
| 10/04/2001 | WO2001072281A2 Microspheres for active embolization |
| 10/04/2001 | WO2001072277A2 Immunotherapeutic methods and compositions |
| 10/04/2001 | WO2001072123A1 Methods for increasing a cytotoxic t lymphocyte response in vivo |
| 10/04/2001 | WO2001040274A3 Inhibition of hrsv membrane fusion |
| 10/04/2001 | WO2001036638A8 Polypeptides and nucleic acids encoding same |
| 10/04/2001 | WO2001036602A3 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same |
| 10/04/2001 | WO2001036456A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 10/04/2001 | WO2001035989A3 Use of anti-idiotypical antibodies as vaccines against cancer |
| 10/04/2001 | WO2001032070A3 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 10/04/2001 | WO2001021784A3 Pcna-associated cell cycle proteins, compositions and methods of use |
| 10/04/2001 | WO2001021773A3 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |